Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland

We evaluated the cost-effectiveness of capsaicin 8% patch (QUTENZA™) versus pregabalin in patients with PNP from the perspective of the National Health Service (NHS) and Personal and Social Services in Scotland, UK. A decision-tree cost-effectiveness model was developed for non-diabetic patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mankowski, Colette, Patel, Sachin, Trueman, David, Bentley, Anthony, Poole, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794144/
https://www.ncbi.nlm.nih.gov/pubmed/26983018
http://dx.doi.org/10.1371/journal.pone.0150973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794144/
https://www.ncbi.nlm.nih.gov/pubmed/26983018
http://dx.doi.org/10.1371/journal.pone.0150973

Ejemplares similares